Effectiveness of mindfulness-based compassion therapy on fear of recurrence, perceived stress and hope in women with breast cancer

Not Applicable

Conditions: Women with breast cancer.
Malignant neoplasm of breast

Registration Number: IRCT20240611062091N1

Lead Sponsor: Islamic Azad University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 30

Inclusion Criteria

At least 4 months have passed since the definitive diagnosis of breast cancer with acuteness levels 1 to 3, and in the second stage of cancer.
Having at least a high school diploma.
Not suffering from other physical illnesses, mental disorders, and addiction.
Not receiving psychological interventions (based on the patient’s file and the opinion of the relevant nurse).
Completion of the consent form.
The possibility of participating in group therapy sessions with the patient’s full consent.
The criteria include having a minimum age of 35 and a maximum age of 50 years old.

Exclusion Criteria

A history of frequent and prolonged hospitalizations.
A history of death due to cancer in the patient’s first-degree relatives.
Receiving any psychological interventions and using strong painkillers (based on the patient’s medical record and the specialist doctor’s opinion).

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fear of recurrence. Timepoint: At the beginning of the study, after the end of treatment sessions, and at the 30-day follow-up stage after the end of treatment sessions. Method of measurement: Fear of Cancer Recurrence Questionnaire (Simard and Savard, 2009).;Perceived stress. Timepoint: At the beginning of the study, after the end of treatment sessions, and at the 30-day follow-up stage after the end of treatment sessions. Method of measurement: Perceived Stress Scale (PSS-14).;Hope. Timepoint: At the beginning of the study, after the end of treatment sessions, and at the 30-day follow-up stage after the end of treatment sessions. Method of measurement: Hope Scale (Snyder et al., 1991).

Secondary Outcome Measures